Welcome to our dedicated page for Alpha Teknova SEC filings (Ticker: TKNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alpha Teknova, Inc. (TKNO) SEC filings page on Stock Titan provides access to the company’s U.S. Securities and Exchange Commission disclosures, along with AI-powered summaries to help interpret the information. As a Nasdaq-listed, emerging growth company, Teknova files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, among other documents.
Recent Form 8-K filings include items furnished under Item 2.02 – Results of Operations and Financial Condition, where Teknova attaches press releases announcing quarterly financial results. These filings incorporate details on revenue by category (Lab Essentials, Clinical Solutions, and Other), gross profit, operating expenses, net loss, and non-GAAP measures such as Adjusted EBITDA and Free Cash Flow or Free Cash Outflow. An 8-K filed in June 2025 also describes the company’s annual meeting of stockholders and the results of director elections and auditor ratification.
Through this page, users can review how Teknova presents its financial condition, operating performance, and governance matters over time. AI-generated highlights can help explain lengthy filings, point out key sections in annual and quarterly reports, and clarify terminology around non-GAAP metrics. For those interested in monitoring TKNO’s regulatory history, this resource also makes it easier to track ongoing current reports and other submissions as they are made available on EDGAR.
In addition to earnings-related 8-Ks, investors can use this page to locate references to the company’s status as an emerging growth company, its Delaware incorporation, and other structural details disclosed in SEC documents. The combination of real-time filing updates and AI-supported summaries is intended to simplify the process of understanding Teknova’s public reporting.
Alpha Teknova, Inc. (TKNO) filed a Form 4 on 25 June 2025 detailing an equity-based compensation award to its General Counsel & Chief Compliance Officer, Damon A. Terrill. The filing reports a single grant of non-qualified stock options covering 137,808 common shares.
The option was granted on 14 February 2025 with an exercise price of $8.28 per share and a ten-year term expiring on 14 February 2035. The award vests in 48 equal monthly installments beginning one month after the grant date, aligning Mr. Terrill’s incentives with longer-term shareholder value creation. There were no open-market purchases or sales of TKNO common stock disclosed, and Mr. Terrill’s post-transaction beneficial ownership consists solely of the 137,808 derivative securities reported.
Because the transaction involves only the issuance of options rather than immediate share issuance, it has no direct impact on current share count or cash flows. However, full exercise would add up to 137,808 new shares to the outstanding share base, representing modest potential dilution. Overall, the disclosure appears to be a routine insider compensation event rather than a signal of changing fundamentals or insider sentiment.
Alpha Teknova, Inc. (TKNO) – Form 4 insider filing
Director Brett Robertson reported the award of 54,300 restricted stock units (RSUs) on 17 June 2025. The award was coded “A” (acquisition) at an indicated price of $0.00, signalling that the shares were granted as part of equity compensation rather than acquired on the open market. According to the footnote, the RSUs will vest in full on the first anniversary of the grant date, subject to continued service.
Following the grant, Robertson’s aggregate direct holding increased to 102,472 common shares. He also reports an indirect ownership of 5,000 shares held in a trust, leaving his total beneficial ownership at 107,472 shares. No derivative securities transactions were reported.
This filing does not provide financial performance metrics, but the incremental equity stake modestly further aligns a board member’s incentives with shareholders. The transaction appears routine in scope and timing and does not, by itself, signal a change in corporate outlook or strategy.
Form 4 filing summary – Alpha Teknova, Inc. (TKNO)
On 02/14/2025 the company granted Chief Financial Officer Matthew Lowell a non-qualified stock option for 169,857 common shares at an exercise price of $8.28 per share. According to the filing, the option vests monthly over 48 equal instalments beginning one month after the grant date and carries an expiration date of 02/14/2035. The transaction is coded “A” (acquired), indicating issuance by the company rather than a market purchase. No non-derivative share transactions were reported.
Following the grant, Lowell directly beneficially owns 169,857 derivative securities; no indirect ownership or additional equity awards were disclosed. The document does not provide information on Teknova’s total shares outstanding, so the potential dilution impact cannot be quantified from the filing alone. There are no sales, open-market purchases, or changes in direct share ownership, and the form contains no amendments to prior reports.
This appears to be a routine element of executive compensation intended to align the CFO’s incentives with long-term shareholder value. Because the award is subject to gradual vesting and requires an $8.28 exercise price, immediate cash outflow from the executive is not involved, nor does the option convey voting rights until exercised.
Alpha Teknova, Inc. (TKNO) filed a Form 4 on 06/25/2025 reporting an equity award to its President & CEO and Director, Stephen Gunstream.
• On 02/14/2025 Gunstream received a non-qualified stock option covering 393,663 shares of common stock at an exercise price of $8.28 per share. The award was coded “A,” indicating an acquisition by grant, and carries an exercise period that expires on 02/14/2035.
• The option vests in 48 equal monthly instalments beginning on the grant date, providing full vesting after four years. No price was paid for the option itself (reported as $0.00), consistent with standard incentive-based grants.
• After the transaction Gunstream directly holds 393,663 derivative securities and reported no indirect holdings. The filing shows no acquisition or disposition of non-derivative (actual share) securities.
This routine incentive grant strengthens management–shareholder alignment through performance-linked compensation, while also adding a potential share overhang equivalent to the optioned amount once exercised.
Alpha Teknova, Inc. (TKNO) – Form 4 insider transaction filed 06/25/2025
Director Martha J. Demski reported the acquisition of 54,300 shares of TKNO common stock on 06/17/2025. The transaction is coded “A,” indicating the shares were awarded, not purchased on the open market. According to the footnote, the shares represent restricted stock units (RSUs) that will vest in full on the first anniversary of the grant date.
Following the award, Demski’s direct beneficial ownership increased to 74,300 shares. No derivative securities were reported in Table II, and the filing does not disclose any sale or disposition of shares.
The filing was signed by attorney-in-fact Damon A. Terrill on 06/25/2025.
- Insider role: Director (not an officer or 10% owner)
- Total shares after grant: 74,300 (direct)
- Grant terms: 54,300 RSUs; vest 100% on 06/17/2026
- Cost basis: $0.00, reflecting equity compensation
This Form 4 reflects routine director compensation via RSUs. While the additional equity strengthens alignment with shareholders, it does not signal an open-market confidence purchase.
Alpha Teknova, Inc. (Nasdaq: TKNO) filed a Form 8-K reporting the results of its 2025 Annual Meeting of Stockholders held on June 17, 2025. A strong quorum of 88.62% of outstanding shares (47,356,521) was present in person or by proxy.
Proposal 1 – Election of Class I Directors: Martha J. Demski and Alexander Herzick were elected to serve until the 2028 Annual Meeting. Each received more than 42.5 million “for” votes, with fewer than 1 million votes withheld and 4.0 million broker non-votes.
Proposal 2 – Auditor Ratification: Grant Thornton LLP was ratified as independent auditor for fiscal 2025 with 47,336,767 “for” votes, representing virtually unanimous support (99.96% of votes cast).
No other matters were brought before shareholders, and the filing contained no financial performance updates or strategic disclosures. These results reflect routine corporate-governance actions with broad shareholder endorsement.